Skip to content
10-Q

Quarterly Report

InspireMD, Inc. NSPR

0001493152-26-021636

← back to feed
Filed
May 7, 2026 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · May 7, 2026 46.84M sh
Shares Diluted Q1 2026 · Mar 31, 2026 83.8M sh
Shares Diluted Q1 2026 · Mar 31, 2025 49.99M sh
Capex Q1 2026 · Mar 31, 2026 $194K
Capex Q1 2026 · Mar 31, 2025 $359K
Operating Cash Flow Q1 2026 · Mar 31, 2026 −$12.34M
Operating Cash Flow Q1 2026 · Mar 31, 2025 −$8.79M
Cash And Equivalents Q1 2026 · Mar 31, 2026 $11.36M
Cash And Equivalents Q1 2026 · Dec 31, 2025 $8.94M
Stockholders Equity Q1 2026 · Mar 31, 2026 $43.62M
Stockholders Equity Q1 2026 · Dec 31, 2025 $55.2M
Stockholders Equity Q1 2026 · Mar 31, 2025 $28.35M
Stockholders Equity Q1 2026 · Dec 31, 2024 $36.09M
Current Liabilities Q1 2026 · Mar 31, 2026 $9.44M
Current Liabilities Q1 2026 · Dec 31, 2025 $10.71M
Total Liabilities Q1 2026 · Mar 31, 2026 $12.85M
Total Liabilities Q1 2026 · Dec 31, 2025 $14.2M
Current Assets Q1 2026 · Mar 31, 2026 $48.59M
Current Assets Q1 2026 · Dec 31, 2025 $61.47M
Total Assets Q1 2026 · Mar 31, 2026 $56.47M
Total Assets Q1 2026 · Dec 31, 2025 $69.4M
Eps Diluted Q1 2026 · Mar 31, 2026 −$0.16
Eps Diluted restated Q1 2026 · Mar 31, 2025 $0.22
Eps Basic Q1 2026 · Mar 31, 2026 −$0.16
Eps Basic restated Q1 2026 · Mar 31, 2025 $0.22
Sga Expense Q1 2026 · Mar 31, 2026 $4.72M
Sga Expense Q1 2026 · Mar 31, 2025 $4.94M
Rd Expense Q1 2026 · Mar 31, 2026 $4.76M
Rd Expense Q1 2026 · Mar 31, 2025 $4.06M
Net Income Q1 2026 · Mar 31, 2026 −$13.69M
Net Income Q1 2026 · Mar 31, 2025 −$11.17M
Operating Income Q1 2026 · Mar 31, 2026 −$13.98M
Operating Income Q1 2026 · Mar 31, 2025 −$11.46M
Gross Profit Q1 2026 · Mar 31, 2026 $687K
Gross Profit Q1 2026 · Mar 31, 2025 $292K
Revenue Q1 2026 · Mar 31, 2026 $3.4M
Revenue Q1 2026 · Mar 31, 2025 $1.53M